{{Rsnum
|rsid=4752
|Gene=GC
|Chromosome=4
|position=71756849
|Orientation=minus
|GMAF=0.1107
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=GC
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 13.1 | 86.9
| JPT | 0.0 | 29.2 | 70.8
| YRI | 6.8 | 44.9 | 48.3
| ASW | 1.8 | 42.1 | 56.1
| CHB | 0.0 | 13.1 | 86.9
| CHD | 0.0 | 13.0 | 87.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 17.3 | 44.5 | 38.2
| MEX | 1.7 | 10.3 | 87.9
| MKK | 9.6 | 28.2 | 62.2
| TSI | 0.0 | 2.9 | 97.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=21844150
|Title=Associations of Vitamin D Binding Protein Gene Polymorphisms with the Development of Peripheral Arthritis and Uveitis in Ankylosing Spondylitis
}}

{{PMID|16600026|OA=1
}} Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway.

{{PMID|18593774|OA=1
}} Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans.

{{PMID|19255064|OA=1
}} Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}